Guest post: Looking out for the invisibly vulnerable in the time of COVID-19
By Guest Contributor | March 26, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Nearly 140 medicines in development to treat mental illness
By Andrew Powaleny | October 10, 2019
Today is World Mental Health Day, a moment where we reflect about the challenges we still face towards better treatment of mental illness and its impact on patients.
Read More
Mental health in the New Era of Medicine
By Bill Chin, M.D. | April 18, 2017
Research and development of innovative medicines to promote mental health are a priority for America’s biopharmaceutical research companies. With more than 130 medicines in development for mental...
Read More
Burden on patients: Access to medicines in health insurance exchange plans
By Allyson Funk | June 23, 2016
Access to prescription medicines is critical to help patients manage their chronic conditions and maximize quality of life. Unfortunately, even with insurance coverage, many patients still...
Read More
Cost of mental illness underscores need for new treatments
By Holly Campbell | May 25, 2016
Today, one in five American adults and children experience a mental illness in any given year. As the prevalence of complex mental health conditions has grown, the cost of caring for patients has...
Read More
Highlighting innovation during Mental Illness Awareness Week 2015
By Hannah Mooney | October 6, 2015
Each year, during the first full week of October, organizations across the country work to raise awareness for mental health disorders to educate the public, fight stigma and provide support....
Read More
Medicare Monday: Research Finds Access to Medicare Prescription Drug Coverage Improved Health Outcomes, Significantly Reducing Depressive Symptoms Among Seniors
By Andrew Powaleny | August 10, 2015
Depression in the U.S. affects more than 6.5 million Americans age 65 and older. The Medicare Part D prescription drug benefit provides seniors and people living with disabilities access to...
Read More
Week in Review: The Latest from PhRMA
By Priscilla VanderVeer | June 19, 2015
Burden on Patients: Access to medicines is important for patients who are managing chronic conditions. In the latest edition of the ”Burden on Patients” series, we’re taking a look at the barriers...
Read More
Burden on Patients: 5 Questions on Access to Mental Health Medicines in Health Exchange Plans
By Allyson Funk | June 18, 2015
Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to mental...
Read More
We Must Work Together to Lessen the Toll of Mental Illness
By Guest Contributor | October 8, 2014
Mental Illness Awareness Week, which takes place the first full week of October, is an opportunity to raise awareness of mental illness and make progress in eliminating stigmas that discourage...
Read More
Medicare Monday (100)
340B Spotlight (43)
Cost & Consequence (0)
